Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary: Background Increased mortality due to cardiovascular disease has been described in adult patients with untreated GH deficiency (GHD). GH replacement has been demonstrate to improve vascular reactivity and reverse early atherosclerotic changes in adults with GHD. Objective Assessment of fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with GHD at baseline and 1 year after GH replacement therapy. Methods We studied 10 patients with GHD (five men and five women; aged 45·6 ± 10·4 years) at baseline and 1 year after GH replacement therapy compared with a control group (nine men and 16 women) matched for age and body mass index (BMI). All subjects, patients and controls, were life‐long nonsmokers, normotensive and nondiabetic. The following variables were recorded: anthropometric and body composition variables, serum concentrations of glucose, insulin and C‐peptide; thrombin anti‐thrombin (TAT) fragments and fibrin degradation product D‐dimer, which were determined by an enzyme‐linked immunosorbent assay (ELISA); IGF‐I by radioimmunoassay (RIA); C‐reactive protein (CRP) by highly sensitive immunonephelometry; E‐selectin, P‐selectin, soluble intercellular cell adhesion molecule‐1 (sICAM‐1), soluble vascular cell adhesion molecule‐1 (sVCAM‐1), interleukin‐6 (IL‐6) and monocyte chemoattractant protein‐1 (MCP‐1) by ELISA. The assessment of endothelial function in vivo was measured with a Doppler device. Results Patients with GHD without GH substitution had higher hip/waist ratio and body fat than controls. Insulin, C‐peptide and triglyceride concentrations were also higher. Our results demonstrated no difference in fibrinogen and in TAT fragment concentrations among patients and controls. E‐selectin concentrations were higher in patients than in controls (26·1 ± 11 vs. 10·7 ± 6·2 µg/l, P = 0·0001). P‐selectin, sICAM‐1, sVCAM‐1, IL‐6, MCP‐1 and CRP were similar in the two groups. Vascular reactivity and carotid intima–media thickness (IMT) were also similar in patients and controls. After 1 year of GH treatment we found no changes in biochemical parameters, fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function. Conclusion Adults with GHD show some subtle changes in soluble adhesion molecules but our data suggest no beneficial effects of GH over these markers in relationship to endothelial function. Factors other than GH treatment, such as differences in age, degree of obesity, the presence of diabetes mellitus and arterial hypertension or tobacco consumption, could explain the observed increase in markers of vascular risk in GH‐deficient patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Bioelectrical impedance analysis—part II: utilization in clinical practice
Kyle, U. G., Bosaeus, I., De Lorenzo, A. D., Deurenberg, P., Elia, M., Manuel Gómez, J., Lilienthal Heitmann, B., Kent-Smith, L., Melchior, J.-C., Pirlich, M., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.09.012 · Cited by 2,350
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
The origins of age-related proinflammatory state
Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults
Gómez, J. M., Espadero, R. M., Escobar‐Jiménez, F., Hawkins, F., Picó, A., Herrera‐Pombo, J. L., Vilardell, E., Durán, A., Mesa, J., Faure, E., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01472.x · Cited by 130
Self-citationThe effects of growth hormone status on circulating levels of vascular growth factors
Silha, J. V., Krsek, M., Hana, V., Marek, J., Weiss, V., Jezkova, J., Rosicka, M., Jarkovska, Z., & Murphy, L. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02303.x · Cited by 31
Hana, V, Prazny, M., Marek, J., Skrha, J., & Justova, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470333 · Cited by 23
Cited by
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Miller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1611 · Cited by 66
Murray, R. D., Wieringa, G., Lawrance, J. A., Adams, J. E., & Shalet, S. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03754.x · Cited by 24
Tanriverdi, F., Karaca, Z., Unluhizarci, K., & Kelestimur, F. (2014) · Endocrine · doi:10.1007/s12020-014-0276-0 · Cited by 20
Metadata
- Authors
- Gómez, J. M., Sahún, M., Vila, R., Domènech, P., Catalina, P., Soler, J., & Badimón, L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2006-04-12
- Volume
- 64
- Issue
- 6
- Pages
- 632-639
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1989405290
- Cited by
- 30
- References
- 10
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. https://app.cochat.ai/papers/10.1111/j.1365-2265.2006.02518.x
- The paper
- Gómez, J. M., Sahún, M., Vila, R., Domènech, P., Catalina, P., Soler, J., & Badimón, L. (2006). Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02518.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.